Pancreatic Cancer Trial, Recruiting NCT03250078 Sponsor: Nuvance Health Condition: Pancreatic Cancer
Back to Pancreatic Cancer

Pancreatic Cancer Trial, Recruiting

NCT03250078
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have at least 2 close family members (parents, siblings, or children) who have had pancreatic cancer.
  • People who have at least 3 family members across multiple generations who have had pancreatic cancer, with at least one of those being a close family member (parent, sibling, or child).
  • People who carry a known high-risk gene mutation (such as BRCA1, BRCA2, MLH1, MSH2, MSH6, PMS2, ATM, PALB2, CDKN2A, or a similar gene) and have at least one close or extended family member who has had pancreatic cancer.
  • People who are at least 50 years old, or at least 10 years younger than the youngest family member who was diagnosed with pancreatic cancer.
  • People who are generally healthy or have only mild limitations in daily activity (this is assessed by the treating doctor using a standard scale).
  • People who have no known reasons they cannot safely have an MRI scan or receive gadolinium contrast dye (a substance used to improve MRI images).
  • People who are willing to have an MRI scan and be checked for any metal implants or past metal injuries before scanning.
  • People whose kidneys are functioning well enough, based on a blood test result above a certain level (confirm specific threshold with trial site).
  • People who are able to give informed consent to participate.
  • People who are willing to return to the study site for all required visits and assessments.

Who may not be able to join:

  • People who have previously been diagnosed with pancreatic cancer.
  • People who currently have cancer that has spread to other parts of the body, or who have received treatment for cancer within the past 5 years.
  • People who have received chemotherapy within the past 6 months (hormonal therapy may be acceptable if the person has been cancer-free for at least 5 years — confirm with trial site).
  • People who have a condition called hereditary pancreatitis.
  • People whose kidneys are not functioning well enough, based on a blood test result below a certain level (confirm specific threshold with trial site).
  • People who have a medical reason they cannot safely have an MRI scan or receive gadolinium contrast dye.
  • People who are currently pregnant or breastfeeding.
  • People who have other serious health conditions that the doctor overseeing enrolment considers would make participation in the trial inappropriate.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Nuvance Health
Registry
ClinicalTrials.gov
Start date
1 November 2016
Est. completion
1 November 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Early Stage Pancreatic Cancer or Precursor Lesions

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov